Cancer eNews - 5 Mar 2021

News, funding, event and opportunities from the combined networks of TCRN, CONCERT and the Cancer Clinical Academic Group.

Vision: Uniting cancer research into a globally-leading partnership to deliver continuing evidence-based practice in diagnosis, intervention, and support.

Subscribe here.

Nerve damage after chemo: potential risk factors revealed

A low haemoglobin count, older age and high BMI are possible risk factors for developing nerve damage after cancer treatment, a UNSW-led study has found.

Understanding ovarian cancer pathways a prerequisite to better therapies

A/Prof Therese Becker discusses the ovarian cancer research being conducted at the Centre for CTC Diagnostics & Research (CCDR).

SPHERE EOI Process: MRFF Rapid Applied Research Translation Funding

SPHERE is managing a rapid Expression of Interest process for the MRFF RART funding scheme to assist its Clinical Academic Groups and partner organisations to short-list, coordinate and uplift applications with the greatest potential for success. All eligible applications will be assessed by an expert review panel and SPHERE Executive members will liaise with successful EOI applicants about progressing to full applications through eligible partner organisations.

You are strongly encouraged to participate in this EOI process if submitting a RART application. See the EOI (link below) and contact Dr Adam Walczak with any enquires.

EOI Deadline: 10 March 2021; CIs notified of outcome 24 March 2021
MRFF RART Round 3 Deadline: 6 May 2021

EOI form

SPHERE support for applications: MRFF 2020 Clinician Researchers initiative

The MRFF 2020 Clinician Researchers Applied Research in Health Grant Opportunity is open, with up to $3M funding for projects completed within 3 years. This grant provides groups of clinician-researchers with funding to build research capacity to validate and implement new approaches that improve the quality and consistency of patient care.

If you're considering applying please in please contact Dr Adam Walczak, SPHERE Executive Team, who can help facilitate your connection with resources and colleagues across the SPHERE partnership and can provide feedback on applications in development.

MRFF Deadline: 12 April 2021

TCRN PhD Candidate Profiles

Recent Articles from TCRN Members

GRANTS

CONCERT’s Infrastructure grants

CONCERT’s Infrastructure grants are available to purchase research infrastructure that cannot feasibly be acquired through national funding that supports cutting-edge infrastructure of critical mass. Non-renewable grants of up to $50K are available and must be expended by 30 June 2021.

Deadline: 31 March 2021

Read more

US Dept. of Defence Ovarian Cancer Research Program

OCRP supports patient-centred research to prevent, detect, treat, and cure ovarian cancer through a range of award mechanisms: Clinical Translational Research Award, Investigator-Initiated Research Award, Early-Career Investigator, Pilot Award and Proteogenomics Research Award.

Deadline: 1 April 2021 (pre-application)

Read more

World Cancer Research 2021 Grants

Funding up to £250K is available for up to three years for grants that support fundamental or translational research into the prevention, diagnosis or treatment of cancer.

Deadline: 2 April 2021

Read more

US Dept. of Defense Lung Cancer Research Program

LCRP will support and integrate research from multiple disciplines for risk assessment, prevention, early detection, diagnosis, and treatment for the control and cure of lung cancer. Research with military relevance is strongly encouraged. Award mechanisms available are: Career Development Award and Concept Award.

Deadline: 6 April 2021 (pre-application)

Read more

NBCF 10 year Chair

The National Breast Cancer Foundation seeks to identify an emerging or established leader in breast cancer research to be hosted at an Australian medical research institute/university who will lead a long-term program of research designed to improve cancer outcomes. The NBCF Chair will have the opportunity to adopt a broad approach that targets breast cancer and may include other cancers.

Deadline: 30 April 2021

Read more

MRFF Funding Opportunities

MRFF EPCDR Initiative – 2020 Neurofibromatosis Research Grant Deadline: 7 April 2021
MRFF Clinician Researchers Applied Research in Health Grant Opportunity Deadline: 12 April 2021
MRFF Rapid Applied Research Translation Funding Deadline: 6 May 2021

NHMRC 2021 Funding Opportunities

NHMRC e-Asia Joint Research Program Deadline: 29 March 2021
2021 Investigator Grants Deadline: 31 March 2021
Partnership Project 2021 PRC1 Deadline: 7 April 2021
2021 Synergy Grants Deadline: 21 April 2021
2021 Ideas Grants Deadline: 5 May 2021

AWARDS, TRAINING AND RESOURCES

NHMRC Biennial Awards: nominations open

NHMRC awards recognise outstanding leadership, innovation and sector contribution, and include the research quality award; consumer engagement award; ethics award; outstanding contribution award; science to art award.

Deadline: 1 April 2021

Cancer Institute NSW Enduring Cancer Data Linkages for Health: EOI

The CanDLe second round of Expressions of Interest for Lead Researchers is open. The Cancer Institute NSW Enduring Cancer Data Linkages for Health Services Research in NSW initiative (CanDLe) launched in August 2020 to provide linked unit record data to a network of approved researchers and aims to advance the pace, quantity and quality of population-wide cancer research that is aligned to the goals of the NSW Cancer Plan.

Deadline: 16 April 2021

Australian Academy of Science 2022 Awards: nominations open

Nominations are now open for the Academy’s 2022 honorific awards, and applications open for support for research conferences, research awards and travelling fellowships.

Deadline: 1 May 2021 (Honorific awards), 1 June 2021 (conferences, awards and travelling fellowships)

Job Opportunities IAEA, Vienna

The International Atomic Energy Agency Vienna, Austria is advertising the following positions: Associate Education Officer (Radiation Oncology) and Radiation Oncologist.

SEMINARS AND EVENTS

Randwick Precinct Cancer Roundtable - Cancer Shared Care

This online workshop is presented by Prof Mark Harris and facilitated by A/Prof Winston Liauw, who have been working together to develop online systems for shared care between GPs and specialist cancer services.

When: 9 March 2021

CONCERT Roundtable: Enabling culturally competent care and research for multicultural communities

Presented by: Lisa Woodland and Ashfaq Chauhan.

When: 10 March 2021

ABOUT US

TCRN
The Translational Cancer Research Network (TCRN) is a translational cancer research centre program funded by the Cancer Institute NSW and is a collaborative and interactive cancer research community based in the South East of Sydney, with links to cancer services and researchers in inner and southern Sydney, and Albury. It was formed to create an innovative and supportive environment for the translation of cancer research into improvements in patient care.

CONCERT
The Centre for Oncology Education, Research and Training (CONCERT) is a translational research centre program funded by the Cancer Insitute NSW. CONCERT exists to bring together the knowledge and expertise of cancer health professionals and researchers to facilitate translation of research generated evidence into practice to achieve better outcomes for those affected by cancer.

Cancer CAG
The Cancer Clinical Academic Group (Cancer CAG) brings together clinicians and researchers from three universities, four cancer services (with six major treatment facilities) and three Medical Research Institutes. Our combined research strength spans the translational medicine spectrum of bench to bedside and health service delivery.

Working with TCRC partners, our network extends to all of the organisations below.

Connect with us

CONCERT

Cancer CAG

TCRN